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Proteinuria, lipoproteins and renal apolipoprotein deposits in unine-
phrectomized female analbuminemic rats. To elucidate the pathogenetic
role of hyperlipidemia per se in the development of glomeruloscierosis,
severely hyperlipidemic female analbuminemic rats (NAR) and mildly
hyperlipidemic male NAR were studied for a period of 37 weeks after
uninephrectomy (UNX). Plasma cholesterol increased from 6.3 0.4
(week 4) to 11.9 0.6 mmol/liter (week 37) in the 9 NAR, and from 4.3
0.1 to 6.4 0.5 mmol/liter in the 3 NAR in the same period. Plasma
protein concentration was also consistently higher in 9 NAR (60 1
g/liter) as compared to 3 NAR (52 1 g/liter). Plasma viscosity was
higher in 9 NAR than in 3 NAR, but there were no differences in blood
viscosity. Proteinuria increased progressively in the UNX 9 NAR from 25
weeks after surgery, reaching a final value of 141 37 mg/day. No
proteinuria occurred in the UNX 6 NAR (final value 15 2 mg/day).
Glomerular capillary pressure, measured prior to the onset of proteinuria,
was not significantly different in UNX 9 NAR and UNX 6 NAR. At the
end of the study glomerulosclerosis and lipid deposition was only found in
the UNX 9 NAR. Throughout the study hyperfiltration and hyperperfu-
sion, relative to the one-kidney clearances of the sham-operated (2K)
animals, were not different in UNX 6 and 9 NAR. No differences were
observed in blood pressure. Hypertrophy, evaluated by glomerular diam-
eters, was less pronounced in UNX 9 NAR (174 3 jim) than in UNX
6 NAR (190 7 jim). Glomerular diameters in 2K 9 and 6 NAR were
similar (respectively 158 2 and 157 4 jim). Plasma apo B levels were
similar (2K 9 NAR: 204 8U; 2K 6 NAR 204 13 U), but cholesterol
and triglyceride content of apo B-containing lipoproteins, namely VLDL,
IDL and LDL, was increased twofold in the 9 NAR as compared to the
6 NAR, implying a larger particle size in the 9 NAR. Deposition of apo
B and apo E was observed in the glomerular mesangium of UNX 9 NAR,
particularly in sclerotic lesions. Glomerular apo A-I deposits were local-
ized primarily in visceral epithelial cells and were not associated with
sclerotic lesions. The development of proteinuria and glomerulosclerosis
after UNX in 9 NAR but not in 6 NAR may depend upon differences in
plasma lipoprotein composition, but is apparently not related to differ-
ences in whole kidney hyperfiltration and hyperperfusion, glomerular
capillary pressure, or blood viscosity.
A variety of pathogenic mechanisms contribute to the progres-
sion of renal disease leading to glomerulosclerosis. Besides a rise
in glomerular capillary pressure (PGC), metabolic disturbances,
notably hyperlipidemia, may play a role [1]. In a 5/6nephrectomy
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model of chronic renal failure, lipid-lowering agents considerably
delayed the development of glomerulosclerosis [2]. In unine-
phrectomized rats a high dietary fat content induced glomerulo-
sclerosis [3]. In a previous study in 3/4 nephrectomized Wistar rats
we found that besides proteinuria, hyalinosis, and endocapillary
proliferation, hypercholesterolemia also correlated with the de-
velopment of glomerulosclerosis [4].
Male rats are used in most studies of renal ablation because of
the rapid development of proteinuria and glomerulosclerosis [2,
4—6]. Female rats are relatively resistant to the development of
proteinuria after uninephrectomy [7] or subtotal nephrectomy [8].
The reason for this gender-linked difference, which seems to
depend on testosterone [9], is probably the milder increase in GC
and less pronounced glomerular hypertrophy in female rats [7, 9].
There were no significant differences in plasma cholesterol in
uninephrectomized male and female rats [9]. From these obser-
vations one might conclude that the rise in GC and glomerular
hypertrophy are the primary causes of the progression of renal
failure. Metabolic disturbances may play a role in the presence of
permanent glomerular hypertension only, for which systemic
hypertension may be a prerequisite [10, 11]. In agreement with the
above, it has been reported that aging male Nagase analbumin-
emic rats (NAR), which are characterized by mild hyperlipidemia
[12], normal arterial pressure [12, 13], and low GC [13], develop
no glomeruloscierosis [12, 13]. In contrast, we recently observed
that normotensive female NAR, which are more severely hyper-
lipidemic than male NAR [12], do develop overt proteinuria by
one year of age, suggesting an important role for the metabolic
disturbance per se in the development of glomerulosclerosis.
In this study we tried to dissociate compensatory hyperfiltration
and glomerular hypertrophy from the development of proteinuria
to elucidate the pathogenetic role of hyperlipidemia per se in the
development of glomerulosclerosis after uninephrectomy. To this
end we monitored plasma lipids, renal function and proteinuria in
male and female NAR repeatedly during a period of 37 weeks
after uninephrectomy or sham operation, and measured glomer-
ular diameter and sclerosis at the end of this period. Furthermore,
to elucidate the role of plasma lipoprotein composition in the
development of glomeruloscierosis, we also evaluated plasma
apolipoproteins and lipoprotein composition in relation to gb-
merular apolipoprotein and lipid deposition.
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Renal damage has been found in rats subjected dietary hyper-
cholesterolemia for 19 to 23 weeks [3, 14]. The damage tended to
be more severe in rats that were also subjected to uninephrectomy
[3, 14]. Dietary hypercholesterolemia increased P0 to similar
values in UNX and 2K rats four to six weeks after surgery, at
which point the rats were virtually free of glomerular injury [14].
It is plausible that the difference in cholesterol and triglyceride
levels in female and male NAR could be accompanied by differ-
ences in P0g. Thus, we measured POC in uninephrectomized
rats at a stage of impending proteinuria. In these rats we also
measured blood and plasma viscosity in view of the association
between blood viscosity, GC and glomerular injury [15] on the
one hand, and the suggested relation with hyperlipidemia [14] on
the other hand.
Methods
Animals
Male (cr) and female (9) NAR (6 to 12 weeks old) from our
own pathogen-free colony (which was founded with animals
generously donated by Dr. S. Nagase, Tokyo, Japan) underwent
right nephrectomy (UNX) or sham operation (2K) under fenta-
nyl/diazepam anesthesia and sterile surgery. Body weight of the
UNX and 2K groups was similar at the time of surgery: UNX d
234 12 g (N = 8), 2K 228 11 (N = 8); UNX 9 187 6 g(N = 10), 2K 9 188 7 g (N = 8). The rats were housed behind
barriers in filter-top cages ( 2 to a cage, 9 3 to a cage). Sentinel
animals that were monitored regularly for infection by nematodes
and pathogenic bacteria, as well as antibodies to a large number of
rodent viral pathogens (ICLAS, Nijmegen, The Netherlands),
were consistently negative throughout the course of the experi-
ment. The rats were provided with a semisynthetic diet (Hope
Farms, Woerden, The Netherlands) containing 20% casein-pro-
tein, 10% corn starch, 5% cellulose, 53% glucose monohydrate,
and 5% soybean oil (by weight). The remaining 7% consisted of
salts, vitamins, and trace elements. Food intake was measured
continuously for the first seven weeks after surgery. Separate
groups of UNX 9 (N = 6) and UNX d rats (N 6) were studied
14 weeks after UNX. The protocol was approved by the Utrecht
University Board for study in experimental animals.
Renal function
Urine was collected after 1, 4, 15, 25 and 32 weeks in the 37
week study and after 11 weeks in the 14 week study for the
determination of creatinine clearance and urinary protein. The
rats were placed in macrolon metabolism cages, with free access
to food and water. Two consecutive 24-hour urine samples were
collected. The animals were then anesthetized with Na pentobar-
bital (60 mg/kg), weighed and 1 ml of blood was sampled by
puncture of the tail artery with a needle (25G). Blood was
collected in heparinized tubes. Renal function was also deter-
mined in pentobarbital anesthetized animals by one hour 51Cr-
EDTA and '251-hippuran clearances after 4, 8, 19 and 33 weeks
[16]. Tail cuff pressure was measured in conscious animals on the
day before the renal function measurements (IITC, San Diego,
CA, USA).
Micropuncture protocol
Micropuncture was performed 14 weeks following UNX. The
rats were anesthetized with pentobarbital sodium (50 mg/kg i.p.)
and prepared for micropuncture as described previously [17].
Briefly, following tracheal intubation, two PE-50 catheters were
placed into the left jugular vein, one for infusion of solutions and
the other for additional anesthetic. A catheter was placed in the
left femoral artery to monitor mean arterial pressure. The left
kidney was approached by a flank incision and placed in a Lucite
holder with an agar wall around the kidney to form a saline well.
A PE-lO catheter was placed in the left ureter for urine collec-
tions. Following surgery, a 60-minute equilibration period was
observed. All animals were infused throughout the experiment
with 0.9% NaC1 containing 15% polyfructosan (mutest, Laevosan,
Linz, Austria) and 0.5% paraaminohippurate at a rate of 20
t1/min. The protocol consisted of two 40-minute periods, during
which timed urine collections were obtained. Plasma samples
were obtained at the beginning and end of the protocol. Two
values for both stop-flow pressure and proximal tubular free-flow
pressure were obtained in each rat, as described previously, using
a servo-null pressure device (Instruments for Physiology and
Medicine, San Diego, CA, USA). At the end of the protocol renal
vein blood was sampled to measure PAH extraction.
Tissue processing
At the end of the experiment all rats were exsanguinated in the
fed state by puncture of the abdominal aorta under pentobarbital
anesthesia. Subsequently the left kidney was perfused in situ for
one minute at a pressure of 100 mm Hg with heparinized (5
lU/mi) phosphate buffered saline, pH 7.4 (PBS), containing 6%
sucrose. After sampling the cranial apex for lipid histochemistry,
the remaining tissue was perfused for an additional two minutes
with 0.025% glutaraldehyde and 2% paraformaldehyde in 0.1 M
phosphate buffer. The fixative was removed by one minute of
reperfusion with the PBS sucrose solution. The sample for lipid
histochemistry was quickly frozen in liquid nitrogen. Coronal
tissue slices, 1 mm thick, were cut from the midportion of the
kidney, fixed in 2% paraformaldehyde in PBS at 4°C for three
hours and processed for glycol methacrylate embedding as de-
scribed previously [18].
Staining procedures for light microscopy
For the immunohistochemical localization of apolipoproteins
and macrophages plastic sections were processed as described
previously [18]. In short, sections were incubated in appropriate
dilutions of rabbit anti-rat polyclonal antibodies directed to apo
A-I, apo E [19], apo B [20] and mouse anti-rat macrophage
antibody (ED 1, provided by Dr. C. Dijkstra, Free University,
Amsterdam, The Netherlands). Endogenous peroxidase was
blocked in PBS, containing 0.06% H202. Second step antibodies,
peroxidase-conjugated swine anti-rabbit IgG (Dakopatts,
Glostrup, Denmark) were applied for one hour at room temper-
ature in a dilution of 1 to 20 in PBS, containing 5% normal rat
serum. Counterstaining was performed using periodic acid-Schiff
and Mayers hematoxylin. To improve morphological detail, sec-
tions were covered with two drops of complete Technovit 8100
medium (solution A+B, 30:1) as used for embedding.
Control experiments were performed to test the specificity of
the antibodies. Previously, double immunodiffusion against puri-
fied antigen ruled out reaction of the polyclonal anti-apolipopro-
tein A-I, E [19], and B (van Tol, unpublished observations) sera
with unrelated antigens in plasma. Rabbit anti-rat antibodies to
apo A-I, apo B and apo E were absorbed with normal rat serum
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(containing all apolipoproteins) in a concentration of 5% for 15 to
30 minutes at room temperature. Subsequently, staining results of
the absorbed antibodies were compared with the unabsorbed.
Absorbance completely removed specific glomerular immune
reactivity for apolipoproteins. Routine control experiments, that
is, replacement of the first antibody by non-immune rabbit serum
or PBS, were consistently negative. Sections were examined under
the light microscope to determine the exact localization of
apolipoproteins and the number of glomerular macrophages.
Lipid histochemisty
Glomerular and tubular lipid deposits were scored in 4 m
frozen sections stained by the Oil Red 0 method (ORO).
Glomeruli were scored semiquantitatively on a scale of 0 to 4+
[18]. Briefly, if 25% of the glomerulus was affected, a score of 1 +
was adjudged, 50% was scored as 2+, 75% as 3+, and 100% as
4+. The ultimate score was then obtained by multiplying the
degree of change by the percentage of glomeruli with the same
degree of injury and additions of these scores. Thus the maximum
score for glomerular lipid deposits was 400. A total number of 50
glomeruli per animal was scored moving from cortex to medulla.
Tubules were also scored semiquantitatively on a scale of 0 to 4+.
Focal deposits in either cortex or medulla were scored as 1+, focal
deposits in cortex as well as medulla were scored as 2+, diffuse
light deposits in cortex and medulla 3+, and diffuse severe
deposits in cortex as well as medulla 4+. Thus the maximum score
for tubular lipid deposition was 4.
Glomerular diameter
Glomerular diameter was measured in PAS stained sections as
described previously [4]. At least 50 glomerular profiles (Bow-
man's capsule) per kidney were traced. Mean glomerular diame-
ters were calculated according to van Damme and Koudstaal [21].
Focal glomeruloscierosis
Focal glomerulosclerosis (FGS) lesions were defined by the
presence of focal and segmental glomerular scarring and obliter-
ation of glomerular capillaries with increased mesangial cellular-
ity, mesangial matrix expansion and adhesion formation between
the tuft and Bowman's capsule. The severity of FGS was scored
semiquantitatively on a scale of 0 to 4+ [22] in PAS stained
sections. Fifty glomeruli were scored per animal with the same
system that was used to assess lipid deposition. Thus the maxi-
mum score for FGS lesions was 400.
Biochemical analyses
Plasma and urinary protein was determined by the Bradford
method. Plasma and urinary creatinine was determined colon-
metrically (Sigma). Urine and plasma inulin concentrations were
assessed photometrically with indoleacetic acid after hydrolyza-
tion to fructose. Urine and plasma PAH concentrations were
assessed photometrically by a chromogenic aldehyde reaction.
Plasma colloid osmotic pressure was measured using a strain
gauge micro-oncometer. Enzymatic methods were used for the
determination of total plasma cholesterol and triglycerides. The
kits were obtained from Boehringer GmbH (Mannheim, Germa-
ny). Plasma concentrations of apo A-I, and apo E were measured
by electroimmunoassay as described previously [19]. Plasma apo B
was determined by radial immunodiffusion, using a specific anti-
serum raised in rabbits against purified rat LDL [20]. Plasma apo
B concentrations, expressed in arbitrary units (A.U.) because of
the insolubility of purified apo B and the lack of sufficient
quantities of pure apo B for use as an absolute standard, were
calculated as percentages of a rat serum standard pool (obtained
from 50 rats) run simultaneously on the plates with the plasma
samples. Six different dilutions of the serum standard pool were
run on each plate. All samples were run in triplicate. Fibrinogen
was measured by electroimmunoassay. Rat fibrinogen was pur-
chased from Sigma (St. Louis, MO, USA) and goat anti-rat
fibrinogen from Nordic (Tilburg, the Netherlands). Three differ-
ent dilutions of the standard were run on each plate. All samples
were run in duplicate. Viscosity measurements of reconstituted
blood (hematocnit 42%) and plasma were performed on a Con-
traves Low Shear 30 viscosimeter (Contraves A.G., Zurich, Swit-
zerland) at 39°C at 7 shear rates (6-50 s'),
Lipoprotein isolation by density gradient ultracentrifugation
Plasma lipoproteins were separated in four UNX ,four 2K ,
four UNX c and four 2K d by density gradient ultracentrifuga-
tion [20] into seven fractions (chylomicrons and VLDL, d < 1.006
gIml; intermediate density lipoprotein, IDL, d 1.006 to 1.019 gIml;
low density lipoprotein; LDL1, d 1.019 to 1.04 g/ml; LDL2, 1.04 to
1.063; HDL2, d 1.063 to 1.125 glml; HDL3, d 1.125 to 1.21 gIml
and an infranatant with a d> 1.21 g/ml). The subdivision of LDL
into LDL1 and LDL2 was performed to separate the apo B
containing lipoproteins from the other particles present in the
total LDL density range of 1.019 to 1.063 gIml [20]. Lipoprotein
TC and TG were measured as described above.
Urinaty protein composition
Protein composition of 16 urine samples was analyzed by
polyacnylamide gelelectrophoresis in the presence of sodium
dodecyl sulphate, as described previously and evaluated with an
image analysis system [20, 23]. The polyacrylamide gels consisted
of a linear gradient of acrylamide from 4 to 10% and a constant
2.6% N'N'-bis-methylene-acrylamide. Standardization was per-
formed using a mixture of two commercial preparations (Sigma
6H and Serva 5) containing proteins with molecular masses
ranging from 6.5 to 205 kD. The molecular masses of the
unknown proteins were estimated by using linear extrapolation
between the two nearest standard proteins in the gel. Sequential
urine samples were analyzed from 4 UNX rats at 4, 15, 25 and
32 weeks post-UNX.
Calculations and statistics
Clearances and excretions were calculated using standard for-
mulae. GFR during the micropuncture experiment was assessed
from inulin clearance, RPF from the clearance of PAH, after
correction for the PAH extraction ratio. P0 was estimated from
PGC = SFPo + ira
in which SFP0 is the stop flow pressure during conditions of
zero-flow and Ira, the colloid osmotic pressure in the afferent
arteriole, which is presumed to equal systemic ir. Glomerular
transcapillary hydraulic pressure (P) was estimated from
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in which T is the proximal tubular pressure under free-flow
conditions.
Hyperfiltration was calculated by normalizing the creatinine or
EDTA clearance found in the UNX animals to 50% of the mean
value found in the 2K animals at the same time point post-
uninephrectomy. Hyperperfusion was similarly calculated using
the hippuran clearance. Proteinuria, glomerular injury score and
glomerular lipid deposition were log-normalized as the distribu-
tion was skewed. Differences in blood viscosity were determined
by analysis of covariance after log-log transformation of the data.
Values were subjected to a two-way completely randomized
analysis of variance. If a variance ratio (F) reached statistical
significance (P < 0.05), the differences between the means were
analyzed by the least significant difference test [24], using the
interaction mean square error to calculate the least significant
difference. Results are expressed as arithmetic means with their
standard errors (5EM), with the exception of lipoprotein compo-
sition (N = 4) where standard deviation (SD) iS presented.
Results
Characterization of the model
No differences were observed in food intake or body weight
during the course of the experiment between the UNX or 2K
animals in either or 9 rats. Final body weights of the UNX and
2K groups were similar at the time of sacrifice: UNX 563 24
g(N=8),2K 593 9 287±6g(N= 10),
2K 9 315 15 g (N = 7). Two rats died in anesthesia, one 2K
at 15 weeks, and one 2K 9 at 33 weeks. Plasma cholesterol levels
were consistently higher in the 9 NAR as compared to the d
NAR (P < 0.01; Fig. 1). Only in the terminal blood samples (after
37 weeks) was cholesterol higher in the UNX 9 NAR than in the
2K 9 NAR (P < 0.05). Plasma triglyceride levels were higher in
the 9 NAR than in the NAR at 25 and 37 weeks (P < 0.01; Fig.
1), but were not increased by UNX. Plasma protein concentration
was always higher (P < 0.01) in the 9 NAR (60 1 g/liter) than
in the NAR (52 1 g/liter), but was not affected by UNX (Fig.
2). Tail cuff pressure was approximately 150 mm Hg at 4, 8, 19 and
33 weeks in all four groups (Table 1).
Proteinuria
At all time points between 1 and 33 weeks after surgery, the
highest individual loss of urinary protein in a rat (irrespective of
whether there were 1 or 2 kidneys present) was 35 mg/day. During
the first 15 weeks the highest loss of urinary protein in a 9 rat was
16 mg/day. Mean values were lower in the first 15 weeks in the 9
NAR than in the NAR (P < 0.01), and there was no effect of
UNX (Fig. 3). However, at 25 weeks after surgery 30% (3 of 10)
of the UNX 9 rats demonstrated manifest proteinuria (45, 67 and
172 mg/day) as compared to 13% (1 of 8) of the 2K 9 rats (42
mg/day). This increased to 80% (8 of 10) of the UNX 9 rats at 32
weeks as compared to 29% (2 of 7) of the 2K 9 rats. Mean urinary
protein loss at 32 weeks was 141 37 mg/day in the UNX 9 rats
versus 17 7 mg/day in 2K 9 rats (P < 0.01).
Electrophoresis of sequential urine samples of four UNX 9
rats that became heavily proteinuric revealed considerable loss of
glomerular protein selectivity (the results found in 2 of these
animals are shown in Fig. 4). At 4, 15 and 25 (3 out of 4 rats)
0 10 20 30 40
Time, weeks
Fig. 1. Plasma cholesterol and plasma triglycerides in uninephrectomized
(UNX) and control (2K) frmale and male analbuminemic rats. Symbols are:
(0) female 2K; (•) female UNX; (V) male 2K; (Y) male UNX. Data are
mean SEM. Females vs. males tP < 0.05 *P < 0.01; UNX vs. 2K *P <
0.05.
weeks, when urinary protein excretion was 7 1 mg/day, three
bands at 13.5, 20.0 and 29.5 kDa can clearly be identified. At 25 (1
out of 4 rats) and 32 weeks, when marked proteinuria (230 39
mg/day) was present, additional bands became prominently visible
between 50 and 75 kDa. In all four animals the bands at 13.5 and
20.0 kDa that were prominent in the early stages could not be
detected at this later stage, whereas a sharp band could be
identified at 12.3 kDa. Note the absence of a dominant albumin
band at 68 kDa in all samples.
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2K9
UNX
9 2K UNX9
N
Week 4
Week 8
Week 19
Week 33
8
162 5
137 4
140 4
149 2
10
146 8
157 5
150 4
153 3
7
143 8
171 6
160 7
155 6
8
165 6
155 5
157 6
152 5
Data are mean SEM.
Whole kidney renal hemodynamics
In UNX rats, hyperfiltration, as assessed by the 24-hour creat-
mine clearance repeatedly between 1 and 33 weeks after surgery,
varied between 150 and 195% of the mean control 1-kidney
filtration (Fig. 5). Hyperfiltration as assessed repeatedly by the
one hour EDTA clearance varied between 140 and 175% of the
mean control 1-kidney filtration (Fig. 5), and hyperperfusion
measured by the hippuran clearance showed a similar increase
(Fig. 5). Importantly, there were no significant differences in
hyperfiltration (on the basis of both creatinine and EDTA clear-
ances) or hyperperfusion between the UNX d NAR and UNX 9
NAR at any time point after surgery.
Glomerular capillary pressure and blood viscosity
Gcand blood viscosity were measured in a subset of UNX rats
14 weeks after surgery. Proteinuria was not present in any of these
rats 11 weeks after UNX, and there was no significant difference
in MAP in 9 and d rats (Table 2). The 9 NAR were markedly
hyperlipidemic as compared to the male NAR. Finally, glomeru-
loscierosis was not observed in any of these rats. Thus the
characteristics of the model described above were also present in
this subset. The 9 rats were considerably smaller than the rats
and left kidney weight, GFR and RPF were lower in UNX 9
NAR than in UNX NAR. Stop flow pressure (SFPO) and colloid
osmotic pressure (ir) were not significantly different in the UNX
9 and UNX & NAR, hence Pc was also not significantly
different. The free flow pressure in the proximal tubules were also
comparable, and therefore there was also no difference in trans-
capillary glomerular hydrostatic pressure. Plasma viscosity was
higher in the UNX 9 NAR than in UNX NAR (P < 0.05), but
there were no differences in whole blood viscosity (Fig. 6).
Plasma apolipoproteins, fibrinogen, viscosity and lipoproteins 37
weeks after UNX
Plasma lipids, apolipoprotein (apo), total protein and fibrino-
gen concentrations and plasma viscosity in terminal blood sam-
ples, 37 weeks after UNX or sham operation, are listed in Table
3. Both plasma apo A-I (P < 0.01) and apo E (P < 0.05) levels are
higher in 9 than in rats. UNX increases plasma apo B
concentration (P < 0.01), and causes a further increase in apo A-I
levels (P < 0.01) in 9 rats. UNX had no effect on any of the
plasma apolipoproteins in the rats. The higher total protein
levels in the 9 NAR (P < 0.01) are not caused by high fibrinogen
levels. On the contrary, fibrinogen levels are slightly higher in the
NAR (P < 0.05). Even in the presence of lower fibrinogen,
higher plasma lipid and total protein levels in the 9 NAR caused
a significant increase in plasma viscosity (P < 0.01).
Lipoprotein cholesterol and triglyceride levels are presented in
Figure 7. There were large increases (P < 0.01) in the apo
+*
80
70
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Time, weeks
Fig. 2. Plasma protein in uninephrectomized (UNX) and control (2K)
female and male analbuminemic rats. Symbols are: (0) female 2K; (•)
female UNX; (V) male 2K; (V) male UNX. Females vs. males +P < 0.05,
P < 0.01.
Table 1. Tail-cuff pressure (mm Hg) in control (2K) and
uninephrectomized (UNX) female (9) and male (d) analbuminemic
rats 4, 8, 19 and 33 weeks after surgery
-
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Fig. 3. Proteinuria (log scale) in uninephrectomized (UNX) and control(2K) female and male analbuminemic rats. Symbols are: (0) female 2K;
(•) female UNX; (V) male 2K; (Y) male UNX. Females vs. males +P <
0.05, #P < 0.01; UNX vs. 2K * < 0.05, **p < 0.01.
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B-containing lipoproteins IDL and LDL1 as well as in the large
HDL-type lipoproteins (LDL2 and HDL2) in the NAR versus
the NAR. No significant differences were observed in HDL3.
UNX as compared to 2K caused a further increase in all lipopro-
teins except HDL3 in the NAR (P < 0.01). UNX also caused
an increase in VLDL cholesterol in the d NAR (P < 0.05). There
were large increases (P < 0.01) in all lipoproteins in the 9 NAR
versus the c3' NAR. Neither in the 9 nor in the NAR was UNX
associated with a further increase in triglyceride level in any of the
lipoproteins.
Renal apolipoprotein and lipid deposition and glomerular
macrophages 37 weeks after UNX
Apo B immunoreactivity was observed in sclerotic lesions of the
UNX 9 rats (Fig. 8A). Glomerular visceral epithelial cells did not
reveal apo B staining. Deposition of apo B was not observed in
any of the other groups. Weak staining for apo E was found in
glomerular visceral epithelial cells and in the mesangium of UNX
9 rats (Fig. 8B). Mesangial deposition was mainly present in
sclerotic areas. In all other groups trace amounts of apo E were
observed in visceral epithelial cells, but not in the mesangium. The
proximal tubules stained strongly for apo E in all animals (Fig.
8B). Moderate immunostaining was observed for apo A-I in
Table 2. Urinary protein 11 weeks after surgery and plasma lipids,
renal hemodynamics and glomerular capillary pressure 14 weeks after
surgery in uninephrectomized (UNX) female (9) and male ()
analbuminemic rats
UNX9 UNX
N 6 6
Body weight g
Kidney weightg
Urinary protein mg/day
251 l9'
1.11 012b
10 21
475 20
2.13 0.1424 3
Mean arterial pressure mm Hg 114 6 118 5
Cholesterol mmol/liter 7.5 O.6 5.5 0.3
Triglycerides mmol/liter 5•5 0.7" 1.8 0.2
Glomerular filtration rate 1.41 0.15a 1.91 0.15
mi/mm
Renal plasma flow mI/mm 3.59 0.47a 5.66 0.67
Stop-flow pressure mm Hg 46.5 2.9 45.6 1.7
Colloid osmotic pressure 12.0 0.7 11.1 0.4
mm Hg
Glomerular capillary pressure 58.5 3.6 56.7 1.9
mm Hg
Proximal tubule pressure 12.8 0.8 13.2 2.1
mm Hg
Glomerular transcapillary 45.7 2.9 43.5 3.7
hydraulic pressure mm Hg
Data are mean SEM.
ap <0.05 vs. "p <0.01 vs.
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Fig. 4. SDS-polyaciylamide gel electrophoresis of proteins in consecutive urine samples obtained from 2 female analbuminemic rats at 4, 15, 25 and 32 weeks
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Fig. 5. Creatinine (A), 51Cr-EDTA (B) and '251-hippuran (C) clearances in
uninephrectomized (UNX) and control (2K) female and male analbumin-
emic rats. Symbols are: (0) female 2K (•) female UNX; (V) male 2K; (V)
male UNX. Values have been normalized to 50% of the mean value found
in control (2K) animals.
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Fig. 6. Blood (A) and plasma (B) viscosity in uninephrectomized (UNX)
female (•) and male (V) analbuminemic rats.
Table 3. Plasma cholesterol, triglyceride, apolipoprotein (Apo), total
protein and fibrinogen concentrations and plasma viscosity in control
(2K) and uninephrectomized (UNX) female () and male (1)
analbuminemic rats 37 weeks after surgery
2K9 UNX9 2Kd UNX
N 6 10 7 8
Cholesterol 11.9 06b 14.3 Ø9lC 6.0 0.3 6.4 0.5
mmollliter
Triglycerides 6.9 1.3" 6.0 1.3" 1.7 0.3 3.0 0.6
mmollliter
Apo A-I 1.58 0.08" 2.00 0.12"' 0.83 0.06 0.81 0.07
giliter
Apo B 204 8 285 22b.d 204 13 218 8
A. U.
Apo E 0.30 0.Ola 0.31 o.ola 0.24 0.01 0.27 0.01
giliter
Total protein 61.7 0.9" 63.3 1.0" 50.4 1.4 51.1 0.8
giliter
Fibrinogen 13.0 1.1" 13.7 1.la 17.8 1.3 17.4 0.5
giliter
Viscosity 1.73 0.06" 1.89 0.08" 1.43 0.04 1.50 0.06
mPa
Apo B concentrations are relative to a standard rat plasma pool with a
concentration of 100 arbitrary units (A.U.). Data are mean SEM.
ap <0.05 vs. C <0.05 vs. 2K
bp <0.01 vs. dp <0.01 vs. 2K
structures (Fig. 8C). This was not unexpected as the proximal
tubule is an important site of apo A-I catabolism [25].
Glomerular lipid deposits were considerably increased (P <
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glomerular visceral epithelial cells of the UNX 9 rats (Fig. 8C). In
2K 9 rats and in both 2K and UNX rats trace amounts of apo
A-I were focally present. Small amounts of apo A-I were found in
the glomerular mesangium. In all animals strong immunoreactiv-
ity for apo A-I was found at the luminal side of proximal tubular
cells in a granular staining pattern, suggestive of lysosomal
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Fig. 7. Plasma lipoprotein cholesterol (A) and plasma l(poprotein triglycer-
ides (B) in uninephrectomized (UNX) and control (2K) female and male
analbuminemic rats. Symbols are: (U) female UNX; (El) female 2K;
male UNX; () male 2K. Females vs. males +P < 0.05; UNX vs. 2K *<
0.05. Data are mean SD. Abbreviations are: VLDL, very low dens-
ity lipoprotein; IDL, intermediate density lipoprotein; LDL, low density
lipoprotein; HDL, high density lipoprotein; LDP, lipoprotein deficient
plasma.
0.01) in UNX 9 (score: 89 21), as compared to 2K 2, UNX
or 2K c (respectively 7 2, 4 2 and 5 2). The median
number of macrophages per glomerulus correlated with the
glomerular lipid deposit score, being 1.35 in UNX 2, as compared
to 0.32, 0.28 and 0.10 in 2K 9, UNX and 2K , respectively.
Thus the UNX 9 rats showed a considerable increase in glomer-
ular apolipoprotein and lipid deposition and glomerular macro-
phages as compared to the 2K 2 rats, whereas there was very little
glomerular apolipoprotein and lipid deposition and very few
glomerular macrophages in the rats.
Glomerular diameter, glomeruloscierosis and interstitial changes 37
weeks after UNX
Mean glomerular diameter was similar in 2K 9 and NAR
(respectively 158 2 and 157 4 m; Fig. 9). UNX increased
glomerular diameter in both 9 and animals (P < 0.05);
however, the increase was more pronounced in the rats (P <
0.05).
Glomeruloscierosis was present in 7 of the 10 UNX 9 (Figs. 8
A and B) with an injury score ranging from 8 to 74. Virtually no
sclerotic glomeruli were observed in the other groups. Proteinuric
animals demonstrated protein casts in dilated tubules, with char-
acteristic interstitial inflammation and tubular atrophy. Interstitial
damage was not observed in non-proteinuric animals. Interstitial
lipid deposits were increased (P < 0.01) in UNX 9 (score: 3.2
0.2), as compared to 2K 9, UNX or 2K d (respectively 1.7
0.5, 0.7 0,4 and 0.2 0.2).
The main finding of the present study is that at similar levels of
hyperfiltration and even less glomerular hypertrophy, UNX 9
NAR develop proteinuria, loss of glomerular permselectivity,
glomerulosclerosis and mesangial apolipoprotein and lipid depo-
sition, whereas UNX NAR do not. In addition, in comparison
to UNX & NAR, no significant difference in GC could be
detected in UNX 9 NAR prior to the development of protein-
uria. Our findings suggest that, besides the renal hemodynamic
changes and renal hypertrophy induced by uninephrectomy, other
factors must play a role in the etiology of renal damage in this
model. These factors probably include hyperlipidemia and plasma
lipoprotein composition. A similar conclusion was reached in a
recent study with a very different model, the 2K Dahl salt-sensitive
rat, where a cholesterol synthesis inhibitor considerably attenu-
ated the development of proteinuria and glomerulosclerosis while
an angiotensin converting enzyme inhibitor did not [26].
Hyperfiltration in & UNX rats has been studied previously in
long-term studies evaluating the effect of varying dietary protein
intake on the development of proteinuria and glomeruloscierosis
[5, 27]. No reports were found directly comparing hyperfiltration
in the first months after uninephrectomy in & and 9 rats of the
same strain. However, comparison of the data from two studies
from Baylis's group in which & and 9 2K [28] and & and 9 UNX
[7] Munich-Wistar rats were studied revealed no major gender-
related differences in the degree of hyperfiltration and hyperper-
fusion after uninephrectomy. On a diet with a protein content
similar to that used in the present study, hyperfiltration in & UNX
Wistar rats, measured by the EDTA clearance, was maintained at
a similar level (about 150% of the mean control one-kidney value)
for 48 weeks [5]. However, these rats developed progressive
proteinuria after only 12 weeks [5], in contrast to the present
findings in & UNX NAR. This supports our contention that
factors other than hyperfiltration play an important role in the
development of proteinuria and glomeruloscierosis after unine-
phrectomy. One such factor may be systemic hypertension [10]. In
spontaneously hypertensive rats severe proteinuria and glomeru-
losclerosis were already present six months after UNX [291.
However, tail cuff pressures were not significantly different be-
tween 9 and & NAR in the present study.
Glomerular hypertrophy has also been considered to be a
pathogenic link between a reduction in the number of nephrons
and the development of glomerulosclerosis [30—32]. However, in
the analbuminemic rat used in the present study the degree of
glomerular hypertrophy after uninephrectomy did not predict the
severity of glomerulosclerosis. In fact, glomerular hypertrophy
was more pronounced in UNX & than in UNX 9 NAR.
It has been suggested that dietary hypercholesterolemia in-
creases P0 via an effect on plasma and blood viscosity [14]. The
increase in blood viscosity may also be an important factor
contributing to the progression of renal injury [33]. By varying
hematocrit and thus modulating blood viscosity, it has been
demonstrated that anemia (hypoviscosity) ameliorates and poly-
cythemia (hyperviscosity) accelerates the development of protein-
uria in the remnant kidney model [15]. However, neither whole
blood viscosity nor P0 were significantly different between UNX
2 and UNX & NAR. Plasma viscosity was slightly higher in the 9
than in the & NAR. This is probably related to differences in the
concentrations of plasma proteins other than fibrinogen as well as
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Fig. 8. A. Deposition of apo B in the glomerular mesangium in a female
analbuminemic rat 37 weeks after uninephrectomy. Plastic section, 500X. B.
Deposition of apo E in the glomerular mesangium in a female analbu-
minemic rat 37 weeks after uninephrectomy. Plastic section, 500x. C.
Deposition of apolipoprotein A-I in the glomerular visceral epithelium in
a female analbuminemic rat 37 weeks after uninephrectomy. Plastic
section, 500x.
the higher triglyceride levels [34]. Besides severe hyperlipidemia,
adult 9 NAR are characterized by normal total protein levels
when compared to normoalbuminemic control rats [23, 35]. This
is in contrast to the adult NAR that are hypoproteinemic [23,
35]. The difference in plasma protein concentration between 9
and NAR is due to higher levels of a number of high molecular
weight proteins [23], such as transferrin and ceruloplasmin in the
9 NAR [35]. In this study we demonstrate that plasma fibrinogen,
one of the acute phase proteins, is lower rather than higher in 9
NARas compared to d NAR. Note that whole blood viscosity was
at least an order of magnitude greater than plasma viscosity.
These data do not support a substantial role for blood or plasma
viscosity and Gc as risk factors for glomerular damage in this
model.
The present study suggests that hyperlipidemia and differences
in lipoprotein composition may be critical in precipitating the
development of proteinuria and glomeruloscierosis after unine-
phrectomy in the 9 NAR. Mechanisms postulated to be involved
in the nephropathic effects of hyperlipidemia include toxic effects
of apo B- and apo E-rich particles, LDL and f3-VLDL, respec-
tively, on the glomerular mesangial cell [36—38] and an enhanced
influx of macrophages [4, 18]. The 9 NAR is consistently more
hyperlipidemic than the d NAR [12, 391. Thiswas also the case in
the present study where the animals were observed from about
two months of age for a period of nearly nine months. The
cholesterol and triglyceride content per particle of apo B-contain-
ing lipoproteins (Fig. 7) appears to be considerably increased in
the 9 NAR as compared to the NAR because plasma apo B
levels were similar in the two 2K groups (Table 3). This implies
that these particles are larger in the 9 NAR than in the NAR.
Thus a primary difference in lipoprotein composition, that is, not
one secondary to proteinuria, may well play a role in the patho-
genesis of early glomerular lesions in this model. Indeed, prelim-
inary findings from our department indicate that performing
ovariectomy in conjunction with UNX in 9 NAR profoundly
decreases plasma triglycerides and completely prevents the devel-
opment of proteinuria and glomerulosclerosis [40].
The deposition of lipid and apo B in the glomerular mesangium
of the perfusion fixed kidneys was parallel to the increased plasma
concentrations of cholesterol and apo B in the proteinuric UNX
9 NAR. Glomerular deposits of apo B [41, 42] have been
observed in biopsies from patients with renal disease, but there
was no relation between cholesterol or apo B concentrations and
the presence or intensity of immunofluorescence in the glomeru-
lus [42]. Thus it is debatable whether the changes observed in the
plasma lipoproteins of subjects that have become proteinuric play
an initiating role in the development of renal lesions. Alterna-
tively, they might be considered as being secondary to some other
primary pathogenic event, although they may well contribute to
SI
:..cr'9'!;.t
Joles et at: Uninephrectomized female analbuminemic rats 451
the development of glomeruloscierosis by foam cell formation [4,
43—45].
Plasma apo F levels were higher in the 9 NAR than in the 5
NAR, a difference also observed previously in NAR on a conven-
tional diet [12], and this protein species was observed in the
mesangium, particularly in sclerotic lesions (Fig. 8B). In another
previous study we observed close proximity of apo E to mesangial
foam cells in a toxic model of the nephrotic syndrome [44].
Glomerular deposits of apo E [41, 42] have also been observed in
biopsies from patients with renal disease. Neither in the present
study, nor in a recent report in patients with glomerular injury [42]
was a relation observed between plasma apo E levels and inci-
dence or intensity of glomerular immunofluorescence. Therefore,
these observations should be interpreted with caution regarding
causality in the pathogenesis of the sclerotic lesion. Although
macrophages avidly take up apo F-rich particles such as /3-VLDL
[46], a phenomenon that has also been observed in glomeruli of
cholesterol-fed UNX rats [47], it is well known that macrophages
synthesize apo £ both in vitro [48, 49] and in vivo when residing in
atherosclerotic plaques [50]. Hence both systemic delivery and
local production could account for deposition of apo £ in the
diseased mesangium. In fact, synthesis of apo E by resident
macrophages may be the initial step in an autocrine process that
draws lipid out of foam cells onto the reverse cholesterol transport
pathway [51]. High plasma apo £ levels may actually be advanta-
geous. Recently, chronic apo £ administration has been shown to
reduce the accumulation of cholesterol esters and reduce plaque
surface area in Watanabe heritable hyperlipidemic rabbits [52]
and transgenic mice overexpressing apo £ demonstrate an accel-
erated clearance of lipoproteins containing apo B [53]. Con-
versely, severe hypercholesterolemia and atherosclerosis develop
in apo E-deficient recombinant mice [54]. Thus both systemic apo
£ concentrations as well as apo £ production by macrophages in
the glomerulus may play a role in the regression of glomerulo-
sclerosis.
Plasma apo A-I levels are higher in the 9 NAR than in the S
NAR. Deposition of this protein was mainly localized in the
glomerular visceral epithelium, whereas lipid deposition was
restricted to the glomerular mesangium. Whether this implies that
the small amount of lipid in apo A-I rich particles is below the
resolution of the ORO stain or that the apo A-I is circulating as
an unbound protein is unclear. Less than 5% of rat plasma apo
A-I is unbound [55]; nevertheless, increased traffic of this small
fraction through a damaged glomerular basement membrane may
account for the positive stain. A similar localization was observed
in nephrotic glomeruli from biopsy material [42]. Apo A-I and apo
B have been demonstrated in the wall of atherosclerotic vessels:
aortae and coronary vessels obtained at autopsy [56] and arteries
of renal allografts in chronic rejection [57]. Localization of apo
A-I deposition outside the mesangium suggests a subsidiary role
in the pathogenesis of glomerulosclerosis.
Summarizing, UNX in 9 NAR leads to proteinuria after four
months and glomerulosclerosis after nine months. Our data
indicate that hyperfiltration and glomerular hypertrophy on the
one hand and severe hyperlipidemia and altered lipoprotein
composition on the other hand play synergistic roles in this model:
in the presence of only hyperfiltration and hypertrophy, as in the
UNX S NAR, or only hyperlipidemia and altered lipoprotein
composition, as in the 2K 9 NAR, glomerulosclerosis is not
found. The relative importance of hyperlipidemia and altered
lipoprotein composition in this model can be appreciated by
realizing that the presence of additional risk factors in male NAR
(higher protein [5, 27] and caloric [58] intake and more rapid body
growth [59]), are not as deleterious as the hyperlipidemia and
altered lipoprotein composition in female NAR.
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